Business Plans › Healthcare
Eye Care / Optical Store Business Plan & Project Report: Industry Trends, Operations Setup, Service Standards, Investment Opportunities, Revenue and Margins
Report Format: PDF + Excel | Report ID: KMR-SVB-033 | Pages: 183
✓ Last reviewed: by KAMRIT research team
Article below is indicative only
This free report description below is to give you an investor-grade overview of the opportunity, CapEx range, regulatory architecture, and project economics. Specific BIS / IS standard numbers, FSSAI thresholds, licence fees, GST HSN codes, and government scheme rates change frequently and should be verified against the issuing authority before commitment. Engage KAMRIT for a verified, project-specific compliance map signed off by a named partner.
Eye Care / Optical Store &: DPR Summary
<p>The India eyewear and optical retail sector stands at a pivotal inflection point, presenting one of the most compelling business-opportunity landscapes in the country's consumer health and retail ecosystem. Valued at USD 11.09 Billion in 2025 by IMARC Group, the India eyewear market is forecast to reach USD 20.86 Billion by 2034, registering a compound annual growth rate of 6.66% over the 2026-2034 period. At the consumer level, eyewear revenue is estimated at INR 32,000 to 35,000 Crores, equivalent to USD 3.5 Billion to USD 3.9 Billion, growing at a steady 5% to 7% annually.
With more than 550 million people in India requiring vision correction and annualized lens consumption estimated at 150 to 170 million units, the addressable demand for optical products and services is massive and structurally underserved.</p><p>The broader India vision care market is valued at USD 2,477.4 Million as of 2025, while the spectacles product segment alone commands a 45.2% share of the total eyewear market, translating to USD 4.27 Billion in 2025. The contact lenses segment is emerging as the fastest-growing category, projected to expand at approximately 7.8% CAGR. Against this backdrop, setting up a well-capitalized, regulatory-compliant optical retail store in India offers a viable and scalable path for entrepreneurs seeking to tap into a market where the unorganized segment has historically dominated but the organized segment is rapidly gaining share through integrated retail chains and online-to-offline models.</p>
CapEx ₹10 lakh - ₹40 lakh for a sub-₹25-lakh micro-enterprise setup in the Indian eye care / optical store sector, with a 2 - 3-year payback against a ₹14,200 crore → ₹34,456 crore by 2032 market (13.5%). Screen time vision strain is the structural tailwind.
The report is positioned for a micro entrant and is structured for direct submission to a commercial bank or NBFC for term-loan sanction under the Means of Finance set out below.
₹14,200 crore in 2026, projected ₹34,456 crore by 2032 at 13.5% CAGR.
Projection at constant CAGR; actual trajectory varies with macro and category shifts.
Regulatory and licence map for this eye care / optical store project
Note: The regulatory items below outline the typical compliance architecture for this project type. Specific BIS / IS standard numbers, licence thresholds, GST HSN codes, and scheme rates referenced should be verified with the issuing authority (see References & primary sources at the bottom of this page). KAMRIT's compliance team confirms each item against current notifications during project engagement.
Eye care / optical store sits under India's strictest regulatory regime (CDSCO at the centre, state Drug Controllers, plus WHO-GMP and Schedule M). For ₹10 lakh - ₹40 lakh CapEx this DPR captures:
- Bio-medical waste authorisation under BMW Rules 2016
- PLI Bulk Drugs (₹15,000 cr) or PLI Medical Devices (₹3,420 cr) participation
- NABH / NABL accreditation if the project includes a clinical or diagnostic arm
- Manufacturing licence under the Drugs and Cosmetics Act 1940 (Form 25/28/28A by category)
- CDSCO + State Drug Controller dual approval for new formulations
KAMRIT files and tracks every one of these approvals end-to-end in the Tier 3 Execution Partnership, including dossier preparation, regulator interaction, fee remittance, and the renewal calendar through year three of operations.
Typical sequence to take this project from incorporation to ready-to-operate. Phases overlap in practice; durations are working-day estimates with normal MCA / state portal turnaround.
Sectoral context for this eye care / optical store & project
<p>The India eyewear market is segmented across multiple product categories and distribution channels, each with distinct growth trajectories. Spectacles remain the dominant segment, with a market size valued at USD 4.27 Billion in 2025 and projected to grow at a CAGR of 7.08% to reach USD 7.91 Billion by 2034. An alternative forecast places the India spectacles market at USD 4.80 Billion in 2026, with projections of USD 10.37 Billion by 2033 at an 11.6% CAGR, reflecting divergent estimates across research firms.
The optical lens sub-market was valued at USD 700 million in 2024 and is growing at a 6.8% CAGR through 2030, while the broader Indian ophthalmic market is estimated at over INR 10,000 Crores.</p><p>Price segmentation reveals a tiered market structure. The low-cost segment is served by local optical shops offering unbranded or economy frames and lenses, while the mid-tier includes organized retail chains and branded products. The premium segment comprises luxury frames and high-index lens technologies.
Distribution channels show offline retail accounting for the largest share, though online channels are growing rapidly. Regionally, North India commands the largest market share at 30.6% to 32.5%, with key clusters in Delhi-NCR, Punjab, Haryana, and Uttar Pradesh, followed by significant demand in the South, West, and East zones. The annualized lens consumption of 150 to 170 million units underscores the sheer volume of a market still heavily reliant on offline optical stores for prescriptions and fittings.</p>
Project-specific demand drivers
- Screen time vision strain
- Brand penetration
- Sunglasses fashion
- Premium lens demand
Ordered by KAMRIT's view of relative importance for this category in India.
Technology and machinery benchmarks
<p>Technology is rapidly reshaping the optical retail value chain in India, from diagnostic equipment to e-commerce platforms and inventory management systems. Modern optical stores require optical diagnostic tools such as auto-refractometers, lensometers, and phoropters for accurate eye examinations and prescription generation. The manufacturing machinery market for optical equipment is valued at USD 500.8 Million as of 2023 and projected to reach USD 596.3 Million by 2030 at a CAGR of 2.5%, indicating steady investment in lab and fabrication technology.</p><p>On the retail operations side, software solutions for optical stores span practice management systems, inventory management platforms, lens-edging laboratory management tools, and customer relationship management modules.
Leading players like Lenskart have invested heavily in omnichannel technology, including proprietary lens-edging labs and virtual try-on capabilities. The broader digital shift is evident in the global optical retail chain market, valued at USD 158.59 Billion in 2025 and projected to reach USD 234.75 Billion by 2034 at a 4.00% CAGR, with technology-enabled chains capturing disproportionate share.</p><p>Emerging sustainability technologies are also gaining attention. Commercial optical spaces aiming for operational efficiency increasingly target LEED (Leadership in Energy and Environmental Design) and ENERGY STAR certifications.
A standard NHS eye test generates approximately 5.27 kg of CO2 emissions, with travel accounting for 69%, energy for 14%, procurement for 11%, and waste for 5% of the total footprint. Energy-efficient LED lighting, smart HVAC systems, and digital record-keeping represent both cost-saving and brand-enhancing investments for environmentally conscious optical retail operations.</p>
Bankable Means of Finance for this eye care / optical store project
For a eye care / optical store project at ₹10 lakh - ₹40 lakh CapEx with a 2 - 3-year payback, the bank-loan-ready Means of Finance KAMRIT recommends is 20-30% promoter equity and 70-80% debt. The primary lender pool for this scale is MUDRA Tarun (up to ₹10 lakh), PMEGP (15-35% subsidy on up to ₹25 lakh). The applicable overlay schemes that materially compress effective cost-of-capital are Stand-Up India ₹10 lakh-₹1 cr for SC/ST/women, CGTMSE collateral-free up to ₹2 cr. The Tier 2 Bankable DPR includes the full vendor-quote-backed CapEx schedule, OpEx model, 5-year revenue projection split by SKU and channel, working-capital cycle, ROI/NPV/IRR, break-even, and sensitivity in three scenarios (base / bull / bear). The model is structured for direct submission to a commercial bank or NBFC credit appraisal team.
Project CapEx ranges ₹10 lakh - ₹40 lakh. Typical split for a viable, bank-ready configuration:
Split is a typical mid-cap manufacturing configuration. Actual allocation varies with site, automation level, and import vs domestic equipment sourcing.
Cumulative free cash from ₹0.25 cr CapEx, indicative breakeven by Year 4-5 at conservative utilisation assumptions.
Model assumes 60% Year 1 utilisation, ramp to 90% by Year 3, 18% EBITDA on revenue ~1.6x CapEx at maturity. Engagement scope refines these to your specific configuration.
Risks and mitigation for this project
<p>Despite the compelling market opportunity, several material risks confront prospective optical retail investors in India. The most significant operational risk is the intense competitive pressure from deep-pocketed organized chains. Lenskart, with its integrated manufacturing, aggressive pricing, and omnichannel presence, has established dominant market share in major urban centers.
Titan Eye Plus leverages the Titan Company's financial resources and brand trust. New entrants must differentiate through specialized services, superior customer experience, or niche product positioning to avoid price-based competition that can erode the industry's healthy 61% gross profit margin benchmark.</p><p>Import dependence poses a supply chain and cost risk. Optical frame imports from China represent 83.25% of total optical frame imports, valued at USD 81,400,678.
Geopolitical tensions, currency fluctuations, or changes in import duties can disrupt supply chains and increase input costs. While the PLI Scheme incentivizes domestic manufacturing, the transition from import reliance is multi-year in nature. Cost of Goods Sold benchmarks ranging from 24% to 35% of gross collected revenue mean that any upward pressure on frame or lens procurement costs directly compresses margins.</p><p>Regulatory compliance carries both administrative and financial costs.
Form MD-42 Registration under the Medical Devices Rules (2017) is mandatory for dispensing Class A and Class B devices including spectacles and contact lenses. Non-compliance can result in penalties or operational shutdowns. BIS quality standards, while protective of brand reputation, add testing and certification costs.
For multi-store operations, navigating State Commercial Establishments Act requirements across different jurisdictions adds complexity.</p><p>Talent and workforce risks are notable. The sector requires licensed optometrists for eye examinations and diagnoses, as well as licensed opticians or optical dispensers certified to fit and dispense frames and lenses based on clinical prescriptions. Shortages of qualified optical professionals, particularly in tier-2 and tier-3 cities, can constrain store operations and service quality.
Training and retaining skilled optical staff represents an ongoing operational investment.</p><p>The unorganized segment's entrenched presence in smaller markets creates pricing pressure. Local optical shops with decades of community relationships and lower overhead structures can compete aggressively on price, making market penetration in semi-urban and rural areas challenging for new entrants. Additionally, the carbon footprint of optical practice operations, with standard eye tests generating approximately 5.27 kg of CO2 emissions, may increasingly attract regulatory scrutiny or consumer preference shifts toward sustainable practices as environmental awareness grows in India.</p>
Category-typical risks plotted by impact and probability. Hover a numbered dot to see the risk.
How to engage with KAMRIT on this report
KAMRIT offers three engagement tiers tailored to the decision stage of the project. Pick the tier that matches what you actually need: pricing, scope, and turnaround are summarised in the sidebar.
Key market drivers
- Screen time vision strain
- Brand penetration
- Sunglasses fashion
- Premium lens demand
Competitive landscape
The Indian eye care / optical store market is sized at ₹14,200 crore in 2026 and is on a 13.5% trajectory to ₹34,456 crore by 2032. Lenskart, Titan Eyeplus and Vision Express hold the leading positions , with Lawrence & Mayo, Specsmakers, Cohens Fashion Optical also profiled in this DPR. The full report benchmarks the new entrant's CapEx (₹10 lakh - ₹40 lakh) and unit economics against the listed-peer cost structure, identifies the specific competitive gap a 2 - 3-year-payback project can exploit, and includes channel-share and pricing-position analysis. Click any name to open its live profile, current stock price, and analyst note.
What's inside the Eye Care / Optical Store DPR
The Eye Care / Optical Store DPR is a 183-page PDF (Tier 2 also ships an Excel financial model) built around a micro entrant assumption. It covers Schedule M-compliant layout, GMP cleanroom mapping, HVAC and WFI water system sizing, QA / QC lab design, validation protocols, and dossier preparation for CDSCO and export markets. The financial side runs the full project economics for ₹10 lakh - ₹40 lakh CapEx: line-itemised CapEx with vendor quotes, OpEx build-up by cost head, 5-year revenue projection by SKU and channel, P&L / balance sheet / cash flow, ROI, NPV, IRR, working-capital cycle, break-even, three-scenario sensitivity, and the Means of Finance recommendation. Payback of 2 - 3 years is back-tested against the listed-peer cost structure of Lenskart and Titan Eyeplus.
Numbers for this Eye Care / Optical Store & project
Market, operating, and project economics at a glance
A focused view of the numbers that decide this micro project. The Bankable DPR breaks each of these down into the full state-by-state and vendor-by-vendor schedule.
Indian market
₹14,200 crore
as of FY26
Forecast
₹34,456 crore by 2032
13.5% CAGR
Project CapEx
₹10 lakh - ₹40 lakh
micro entrant
Payback
2 - 3 yrs
base-case scenario
GMP CapEx
₹8-14 cr / line
tablet line, Grade C
Validation cost
₹40-80 lakh
WHO-GMP audit ready
DPCO exposure
~14%
NLEM essential category
GST rate
5-12%
formulations vs APIs
City-specific versions of this report
Setting up in your city? 20 location-specific overlays included.
Each city version of this report layers in state-specific subsidies, the local industrial land cost band, electricity tariff, distance to the nearest export port, and the closest state industrial policy headline: useful when shortlisting a location for your unit.
Table of Contents
20 chapters, 183 pages. Excel financial model included with Tier 2 and Tier 3.
FAQs about this Eye Care / Optical Store & project
Does this eye care / optical store project need Schedule M cleanrooms?
For formulations: yes, Schedule M (revised) is mandatory from 2024. Grade D / C / B classification depends on dosage form. KAMRIT sizes the HVAC, WFI water system, and cleanroom CapEx accordingly within the ₹10 lakh - ₹40 lakh envelope.
WHO-GMP and US-FDA , which export markets does this DPR target?
KAMRIT structures the dossier for WHO-GMP (regulated emerging markets) by default. US-FDA (ANDA filing) and EU-GMP add 18-24 months to the timeline and 35-50% to validation CapEx. The Tier 2 DPR runs both scenarios.
Is the project under DPCO / NLEM price control?
Essential medicines on the NLEM are price-controlled by NPPA. KAMRIT confirms upfront whether the product portfolio is exposed, since DPCO controls compress gross margin by 8-14 percentage points.
What CDSCO approvals apply?
For new formulations, dual approval from CDSCO and the State Drug Controller. Form 25/28/28A depending on category. Bioequivalence studies for generics. KAMRIT handles the dossier preparation, regulator interaction, and audit readiness.
What is the typical payback for eye care / optical store?
For ₹10 lakh - ₹40 lakh CapEx, KAMRIT's base case lands payback at 2 - 3 years assuming 70% capacity utilisation by Year 3. Export-led units (with 30%+ revenue from US/EU) hit payback 12-18 months faster.
How quickly can KAMRIT start on this project?
KAMRIT begins the file within one business day of the engagement letter. Tier 1 Industry Insights Report ships in 7 business days, Tier 2 Bankable DPR with Excel model in 14 business days, and Tier 3 Execution Partnership is custom-scoped 6-18 months depending on the project envelope.
Not sure which tier you need?
Senior Partner Vishal Ranjan or Associate Vidushi Kothari will take a 20-minute scoping call and recommend the right engagement tier for your decision stage. Response within one business day.
Regulatory references and primary sources
Claims in this report reference the following Indian regulators, Acts, and authoritative portals.
- Ministry of Corporate Affairs (MCA), Government of India
- Companies Act 2013
- Income-tax Act 1961
- Central Goods and Services Tax (CGST) Act 2017
- Micro, Small and Medium Enterprises Development Act 2006
- Udyam Registration Portal (Ministry of MSME)
- Central Drugs Standard Control Organisation (CDSCO)
- Ministry of Health and Family Welfare
- National Health Authority (Ayushman Bharat)
References open in a new tab. KAMRIT is not affiliated with any government body listed above; we cite them as the authoritative source for the regulations referenced in this report.
Related reports in Healthcare
Other bankable project reports in the same sector, ready for download.